Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.723
+0.033 (0.70%)
Mar 20, 2026, 11:28 AM EDT - Market open
Molecular Partners AG Stock Forecast
Stock Price Forecast
The 2 analysts that cover Molecular Partners AG stock have a consensus rating of "Buy" and an average price target of $8.38, which forecasts a 77.45% increase in the stock price over the next year. The lowest target is $3.75 and the highest is $13.
Price Target: $8.38 (+77.45%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molecular Partners AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +175.28% | Mar 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +175.28% | Jan 27, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $4 → $3.75 | Hold | Maintains | $4 → $3.75 | -20.59% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $4.5 → $4 | Hold | Maintains | $4.5 → $4 | -15.30% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $6.6 → $4.5 | Hold | Maintains | $6.6 → $4.5 | -4.71% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
6.89M
Revenue Next Year
28.82M
from 6.89M
Increased by 318.52%
EPS This Year
-1.52
from -1.65
EPS Next Year
-0.46
from -1.52
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 23.1M | 113.4M | |||
| Avg | 6.9M | 28.8M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 1,547.1% | |||
| Avg | - | 318.5% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.62 | 1.52 | |||
| Avg | -1.52 | -0.46 | |||
| Low | -1.93 | -2.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.